跳至主要内容
临床试验/IRCT20160827029535N3
IRCT20160827029535N3尚未招募未知

The comparison of the efficacy of ranitidine plus metoclopramide with lansoprazole plus metoclopramide in the recovery rate of signs and symptoms of neonatal gastro esophageal reflux disease unresponsive to conservative and monotherapy.

Investigator0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 30 days(—)
性别
All

入选标准

  • Healthy term neonates aged 1–30days with GERD not responding to conservative therapies including antireflux positioning, milk thickening, hypoallergic regimens and monotherapy.

排除标准

  • 1-Neonates with any underlying diseases, including anomalies or gastrointestinal obstruction, neurological disorders, sepsis, NEC, etc.2-Using any sedative , relaxant or anticonvulsive medications .3-History of ventilation therapy.

研究者

发起方
Investigator

相似试验